COPD Patients' daily lives studied in major treatment review
NCT ID NCT03963167
Summary
This study followed 661 Italian adults with moderate to severe COPD for one year while they used the Trimbow® inhaler as prescribed by their doctors. Researchers wanted to see how this medication affected patients' daily symptoms, quality of life, and how consistently they used their inhaler in real-world conditions. The study measured breathing tests, symptom scores, sleep quality, and hospital visits to understand the treatment's practical benefits.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione Policlinico Gemelli
Rome, Italy
Conditions
Explore the condition pages connected to this study.